RHEUMATOID ARTHRITIS (RA) Gergely Péter dr RHEUMATOID ARTHRITIS (RA) Gergely Péter dr Definition: Chronic destructive diseases characterized by joint inflammation.

Slides:



Advertisements
Similar presentations
RHEUMATOID ARTHRITIS RA Inson lou. Epidemiology Symptoms signs Labs Diagnosis Treatment.
Advertisements

doc.MUDr. Želmíra Macejová, PhD III. Internal clinic LF UPJŠ
Rheumatoid Arthritis John Imboden MD.
Rheumatoid Arthritis and Osteoarthritis
Rheumatoid Arthritis Systemic chronic inflammatory disease
Hatem H Eleishi, MD Professor of Rheumatology, Cairo University Consultant Rheumatologist, Dr. Soliman Fakeeh Hospital Rheumatoid Arthritis Wednesday,
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
1987 Revised Criteria for classification of RA 1.Morning stiffness * 2.Arthritis ≥ 3 joints * 3.Arthritis of PIP, MCP or Wrist * 4.Arthritis is Symmetric*
RHEUMATOID ARTHRITIS VS OSTEOARTHRITIS Anusha Reddy FY1 General Surgery (UHCW) 25 th Nov 2013.
Dr Jaya Ravindran Consultant Rheumatologist Walsgrave Hospital
Dr. Fahim Khan MBBS,MD,MRCP(UK),FRCPLondon,FRCP Edin, FACP Rheum CONSULTANT RHEUMATOLOGIST Aut Even Hospital, Kilkenny Whitfield Clinic Waterford,The St.
1 IN THE NAME OF GOD. 2 Rheumatoid Arthritis A chronic multisystem disease Characteristic feature: Persistent inflammatory synovitis Peripheral joints.
Rheumatoid Arthritis John Imboden MD.
Table 1. Comparison between the provisional diagnosis based on the proforma versus final diagnosis Early arthritis Rheumatoid arthritis 3 6 Psoriatic.
Rheumatoid arthritis for finals By Paula Roberts FY1.
IMPROVING EARLY DIAGNOSIS AND TREATMENT OF RHEUMATOID ARTHRITIS Michael Lockwood, MD, FACP, FACR Rheumatology Indiana University Health Arnett.
Approach patient with ARTHRITIS DR. MOHAMMED O. AL-RUKBAN Assistant Professor Department of Family and Community Medicine College of Medicine King Saud.
detection of Rheumatoid factor by using LatexAgglutination
RHEUMATOID ARTHRITIS. Chronic multisystem disease of unknown cause Characteristic features: Persistent inflammatory synovitis Involves peripheral joints.
RA- Epidemiology/ Genetics  Most common inflammatory arthritis  Prevalence: 0.8 % of population ( increasing prevalence with age)  M:F 1:3  Age range:
Rheumatoid arthritis vs Osteoarthritis Katy Davidson and Hannah Brown.
All About Rheumatoid Arthritis
Treatment of Rheumatoid Arthritis Then and Now
OA vs RA Alastair Stephens Matt Vreugde. What are the 5 functions of bone? Function SupportProtection Movement Haematopoiesis Mineral Homeostasis.
Management of Rheumatoid Arthritis Morning stiffness Morning stiffness in and around the joints, lasting at least 1 hour before maximal improvement.
Rheumatoid Arthritis(RA)
Disease –Modifying Antirheumatic drugs
1031 MD4. Jane is a 45 year old woman, who presents to her doctor complaining of morning stiffness of the joints of her fingers for several weeks now.
HPI A 35yo receptionist presents to your office complaining of intermittent episodes of pain, stiffness, and swelling in both hands and wrists for approximately.
Orthopaedics Wa’el N. Qa’dan, MSc. Rheumatoid arthritis (RA): It is the commonest cause of chronic inflammatory joint disease. Most typical.
( Slow Acting Anti-inflammatory Drugs ). OBJECTIVES At the end of the lecture the students should Define DMARDs Describe the classification of this group.
Nursing Management: Arthritis and Connective Tissue Diseases
Rheumatoid Arthritis Dr ahad azami. Rheumatoid Arthritis Systemic Systemic Chronic Chronic Inflammatory Inflammatory Primarily targets the synovium of.
Rheumatoid Questions and Notes on OA and RA. A patient presents with rheumatoid arthritis. On examination of her hands, she has several joint deformities.
Dr. Hanan AL Rayes, MD Consultant Rheumatology
Rheumatoid arthritis.
DR.A.Tahamoli Rudsari.  Rheumatoid arthritis (RA) is a chronic multisystem disease of unknown cause.  Although there are a variety of systemic manifestations,
Rheumatoid Arthritis(RA) Dr. Gehan Mohamed. Learning objectives: At the end of this lecture the student should be able to : understand definition,genetic.
IIIB – DOCTOR OF MEDICINE B5 Dr. Tan - Ong. ACR classification criteria Morning stiffness Arthritis of three or more joint areas Arthritis of hand joints.
Adult Medical-Surgical Nursing Musculo-skeletal Module: Rheumatoid Arthritis.
LSU Clinical Pharmacology
Approach to the Treatment of RA Try to figure out ‘what type’ of Rheumatoid Arthritis the patient has This is not a uniform disease Young, Sero-positive.
Overview of Rheumatoid Arthritis Naureen Mirza, MD May 10, 2010.
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
( Slow Acting Anti-inflammatory Drugs ). OBJECTIVES At the end of the lecture the students should Define DMARDs Describe the classification of this group.
BY PROF. AZZA EL-MEDANY DR. OSAMA YOUSIF General Features & Conditions to use antirheumatic Low doses are commonly used early in the course of the disease.
Rheumatoid Arthritis Systemic chronic inflammatory disease
Disease modified Anti-rheumatic drugs ( DMARD)
Rheumatoid Arthritis Christine Aranyi and Rebecca Boon State university of new york institute of technology Pathophysiolog y Rheumatoid Arthritis (RA)
RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.
1 IN THE NAME OF GOD. 2 Rheumatoid Arthritis A chronic inflammatory disease A systemic disease Characteristic feature: Persistent inflammatory synovitis.
Rheumatology Normal Anatomy andPhysiology. Synovial joints: Normal Anatomy 1. Bone: 2. Cartilage: 3. Synovium:
Inflammatory Arthropathies Kyung Dong University Dept. of Occupational Therapy Kim Chan Mun Ankylosing Spondylitis(AS) Rheumatoid Arthritis(RA)
Disease Modifying Antirheumatic drugs. At the end of the lecture the students should: Know the pathogenesis of rheumatoid joint damage Emphasize the rational.
Introduction to collagen-vascular diseases. Definition: Rheumatologic (or Rheumatic) Disease: diseases characterized by pain and inflammation in joints.
Musculoskeletal manifestations
The following diseases are accompanied by changes in the joints:
to Rheumatological Diseases
Arthritis All answers are TRUE for the T/F questions.
Approach to diagnosis of Rheumatoid arthritis
Rheumatoid arthritis.
RHEUMATOID ARTHRITIS Dr.Fakhir Yousif.
Epidemiology of rheumatoid arthritis
Enteropathic Arthropathy
Rheumatoid Arthritis Objectives:
polyarthritis –clinical approach
Epidemiology of rheumatoid arthritis
Disease Modifying Anti-rheumatic drugs
Rheumatoid Arthiritis
Presentation transcript:

RHEUMATOID ARTHRITIS (RA) Gergely Péter dr RHEUMATOID ARTHRITIS (RA) Gergely Péter dr Definition: Chronic destructive diseases characterized by joint inflammation with pain and swelling. In a considerable proportion of patients, the arthritis is progressive, resulting in joint destruction and ultimately incapacitation and increased mortality. Relatively common, prevalence: %, the male:female ratio cca. 1:3. Typical case: woman aged years with polyarthritis and early joint deformities. RHEUMATOID ARTHRITIS (RA)

Endogenous factorsExogenous factors MHC genes, hormon milieu)cross-reacting antigenes, bacteria, viruses Synovial vasculitis Adhesion molecule expressioncellular infiltration Macrophages, T cells, B cells, granulocytes Cytokines (TNF- , IL-1, IL-6), RF, free-radicals, enzymes Synovial proliferation, angiogenesis, chondrocyte-, osteoclast- activation Pannus, cartilage destruction, bone resorption Pathogenesis of RA

Cytokinek interakciói Cytokine interactions Cytokine interactions

Picture

Classification criteria of RA (ARA, 1987) 1.Morning stiffness – for at least 1 hr and present for at least 6 weeks 2.Swelling of 3 or more joints for at least 6 weeks 3.Swelling of wrist, metacarpophalangeal (MCP) or proximalinterphalangeal (PIP) joints for at least 6 weeks 4.Symmetric joint swelling 5.Typical radiologic changes in hands (erosions or unequivocal bony decalcification) 6.Rheumatoid nodules 7.Serum rheumatoid factor (RF) positivity Diagnosis is made by the presence of 4 or more criteria

Differential diagnosis of polyarthritis RA should be differentiated from: - Other autoimmune diseases (SLE, primary Sjögren’s syndrome, MCTD, PM/DM, PSS, PAN, gian cell vasculitis, polymyalgia rheumatica, adult onset Still’s disease) - Viral diseases (parvovirus B19 infection, rubella, hepatitis B & C infection) - Bacterial infections (tbc, rheumatic fever, Jaccoud’s arthritis, septic endocarditis, mycoplasma arthritis) - Seronegative spondylarthritides (erosive psoriatic arthitis, reactive arthritis, enteropathic arthritis) - Paraneoplastic arthritis - Other diseases (e.g. hyperthrophic osteoarthropathy, erythema nodosum, agammaglobulinemia, acromegaly, diabetes mellitus) - Other rheumatic diseases (chronic gout, inflamed erosive osteoarthritis) Differential diagnosis of polyarthritis

Signs of early RA (=undifferentiated arthritis) In the early stage (within the first 3-6 months) (ARA) classification criteria cannot be used. The patient should be referred to a rheumatologist, if the patient has 3 or more swollen joints the metacarpophalangeal (MCP) and/or metatarsophalangeal (MTP) joints are involved; the squeeze test is positive morning stiffness is 30 min or more.

Squeeze test

Joint involvement in RA The most specific sign of RA is arthritis. It is progressive and deforming in the majority (2/3) of cases (= erosive polyarthritis)

RA early stage

Early assymmetric RA

PIP joint involvement in RA

RA: swan neck deformity

RA: ulnar deviation

Ulnar deviation in RA with severe atrophy of interosseal muscles Ulnar deviation in RA with severe atrophy of interosseal muscles

RA: Boutonnière deformity

RA: arthritis mutilans

Involvement of joints of feet in RA

Severe destruction of ankles in RA

Periarticular osteoporosis (decalcification)

Erosions and sclerosis (in late stage)

Erosion in RA

Early erosions (MRI)

Scinti- graphy of the hands Scinti- graphy of the hands

Baker’s cyst

Bursitis in the shoulder

Bursitis and rheumatoid nodule

Rheumatoid nodules

Atlantoaxial subluxation Atlantoaxial subluxation

RA – end stage

Extraarticular manifestations of RA rheumatoid nodules – subcutaneous - in internal organs (lung, aortic valve) pleuritis/pericarditis fibrotizing alveolitis Felty’s syndrome vasculitis amyloidosis

Systemic manifestations of RA: pulmonary fibrosis Systemic manifestations of RA: pulmonary fibrosis

Interstitial pneumonitis in RA

Systemic manifestations of RA: Caplan’s syndrome Systemic manifestations of RA: Caplan’s syndrome

Rheumatoid nodules in the lungs

Episcleritis in RA

Scleritis in RA

Scleromalacia perforans

Vasculitis in RA

Leg ulcers in Felty’s syndrome

Large granular lymphocytes in Felty’s syndrome

Disease modifying antirheumatic drugs (DMARD) Disease modifying antirheumatic drugs (DMARD) : DrugAdverse effectsDose gold (i.m.) dermatitis, stomatitis, mg /2-4 proteinuria, enterocolitis, weeks thrombocytopenia gold (p.o.)less frequently used, brecause of lower tolerability chloroquine (hydroxy-retinopathia, pigment-250 mg/day chloroquine)anomalies Regular ophthalmology check is required d-penicillamineproteinuria, myasthenia, mg/day stomatitis Owing to low tolerability it is not used any more azathioprinehepatitis, bone marrow depression mg/day Scarcely given in RA methotrexatehepatotoxicity, pulmonary fibrosis, 7,5-25 (MTX)bone marrow depressionmg/week most frequently used therapy Disease modifying antirheumatic drugs (DMARD)

sulfasalazinenausea, vomiting1,5-2 g/day diarrhea, bone marrow depression cyclosporine Anephrotoxicity, tremor1,5-4 mg/kg/day creatinine and blood pressure should be checked regularly leflunomidehepatotoxicity, GI10-20 mg/day complaints TNF-  blockers: local reaction, autoimmune disease (SLE, SM) (etanercept, infection (tbc) infliximab, and abatacept) etanercept: 25 mg 2x weekly s.c. infliximab: 3 mg/kg every 8 week i.v. Other: anakinra (IL-1 blocker) rituximab (anti-CD20 antibody) abatacept (T cell activation blocker antibody) sulfasalazine

Diseases related to RA: 1)Juvenile forms (= juvenile RA, juvenile idiopathic arthritis (JIA) Subgroups: a)systemic (Still’s disease) b)pauciarticular (<4 joints) c)polyarticular (similar to adult RA) 2) Seronegative (RF negative) forms (seronegative spondarthropathies = SNSA) a)Ankylosing spondylarthritis (Mo Bechterew) b)Psoriatic arthritis c)Reiter’s disease - postinfectious arthritis d)Enteropathic arthritis Diseases related to RA:

Classification criteria of JIA (ARA, 1982) 1. Persistent arthritis of at least 6 weeks duration in one or more joints 2. Exclusion of other causes of arthritis (in particular): a. other systemic autoimmune diseses (SLE, rheumatic fevers, vasculitis, PSS, SS, MCTD, Behçet’s syndrome, PM/DM, SPA, Reiter’s syndroma, psoriatic arthritis) b. Infectious arthritis c. Inflammatory bowel diseases d. Neoplasms (e.g. leukaemia) e. Nonrhematic conditions f. Hematologic diseases g. Psychogenic arthralgia h. Other (sarcoidosis, hyperthrophic osteoarthropathy, villonodular synovitis, chronic aktive hepatitis, familial Mediterranean fever)

Child with advanced polyarticular JIA

Micrognathia in JIA

Typical skin rash in Still’s disease Typical skin rash in Still’s disease

Inflamed joints with diffuse edema in SNSA (‘sausage-like’ fingers)

Involvement of DIP joint in SNSA

Asymmetric (MTP) arthritis in SNSA

Skin and nails in psoriasis Skin and nails in psoriasis

Exanthema in the rare adult onset Still’s disease Exanthema in the rare adult onset Still’s disease